The effects of SLE sera were inhibited by the addition of B18R, but not neutralizing antibodies to IL-12 or IFN-γ, indicating that IFN-I was the major factor responsible for CD64 upregulation (Figure 4c and 4d). The gene discussed is FCGR1A; the disease is systemic lupus erythematosus.